Integrative Therapeutics™ Launches Clinically-Proven Pro-Flora™ Women’s Probiotic
GREEN BAY, WI (September 4th, 2012)—Leading supplement manufacturer, Integrative Therapeutics, has launched Pro-Flora Women’s Probiotic: a clinically-proven Lactobacillus GR-1® and RC-14® combination.
Dr. Tori Hudson, ND, Program Director for the Institute of Women’s Health and Integrative Medicine, emphasizes the need for condition-specific probiotic supplementation for women, “Vaginal health concerns are one of the leading reasons women visit healthcare practitioners, and balancing vaginal microflora is essential for maintaining vaginal health. Using a probiotic designed and clinically-studied for treating flora imbalances in the vaginal tract is extremely important.”
Pro-Flora Women’s Probiotic is a combination of two proprietary, clinically-proven Lactobacillus strains, Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14, that are supported by more than 20 years of clinical research in supporting urogenital health.*1-3
A randomized, placebo-controlled clinical trial demonstrated vaginal colonization following oral administration to 64 healthy women. Participants took a capsule containing GR-1 and RC-14, or a matching placebo, once per day for 60 days. The combination was found to significantly and beneficially alter the vaginal flora.* Culture findings confirmed a significant increase in Lactobacilli at day 28 and day 60.* At day 28, individuals who received GR-1 and RC-14 demonstrated improved yeast balance.*1
This combination is also safe to use with pregnant women, and can be used with conventional options for urogenital health.*2
For more information on the clinically-studied probiotic strains in Pro-Flora Women’s Probiotic, visit www.IntegrativeInc.com.